de Luca C, Olefsky JM
Zeisel SH, Warrier M
Eli Lilly and Company is the pharmaceutical company that makes two tirzepatide products that are approved by the Food and Drug Administration (FDA): Mounjaro, which is approved by the FDA for improving blood sugar levels in people with Type 2 diabetes, and is often prescribed off-label for weight loss Zepbound, which is FDA approved for weight loss, as well as for obstructive sleep apnea in adults with obesity Currently, there are no FDA-approved generic versions of the drugs Mounjaro or Zepbound, and there are not any other FDA-approved tirzepatide products available besides brand-name Mounjaro and Zepbound
Tirzepatide's most common side effects are nausea, vomiting, and diarrhea, all of which cause fluid loss
USA Today noted that while employers often cover the cost of diabetes medications such as Ozempic and Lillys Mounjaro for their workers, employers are less likely to pick up the tab for weight-loss medications. KFF, quoted in the USA Today article, said 43% of larger employers paid for anti-obesity drugs last year
Is that syringe full of B vitamins, lipotropes, phentermine, or something else
